Hangzhou Minsheng Healthcare Co Ltd (301507) - Total Assets
Based on the latest financial reports, Hangzhou Minsheng Healthcare Co Ltd (301507) holds total assets worth CN¥2.09 Billion CNY (≈ $305.92 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hangzhou Minsheng Healthcare Co Ltd - Total Assets Trend (2021–2025)
This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 301507 company net worth for the company's overall valuation and market capitalisation.
Hangzhou Minsheng Healthcare Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Hangzhou Minsheng Healthcare Co Ltd's total assets of CN¥2.09 Billion consist of 60.1% current assets and 39.9% non-current assets. Review Hangzhou Minsheng Healthcare Co Ltd balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.4% |
| Accounts Receivable | CN¥24.31 Million | 1.2% |
| Inventory | CN¥103.83 Million | 5.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥83.64 Million | 4.2% |
| Goodwill | CN¥69.99 Million | 3.5% |
Asset Composition Trend (2021–2025)
This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Hangzhou Minsheng Healthcare Co Ltd stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hangzhou Minsheng Healthcare Co Ltd's current assets represent 60.1% of total assets in 2025, a decrease from 60.7% in 2021.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, up from 3.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 5.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 5.2% of total assets.
Hangzhou Minsheng Healthcare Co Ltd Competitors by Total Assets
Key competitors of Hangzhou Minsheng Healthcare Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pfizer Inc
NYSE:PFE
|
USA | $201.13 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $136.46 Billion |
|
Merck & Company Inc
NYSE:MRK
|
USA | $129.80 Billion |
|
AstraZeneca PLC
MX:AZNN
|
Mexico | MX$114.07 Billion |
|
Novartis AG ADR
NYSE:NVS
|
USA | $122.03 Billion |
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357
|
China | CN¥2.89 Billion |
|
Firebrick Pharma Ltd
AU:FRE
|
Australia | AU$2.28 Million |
|
Eli Lilly and Company
SA:LILY34
|
Brazil | R$116.58 Billion |
Hangzhou Minsheng Healthcare Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.83 | 5.86 | 6.73 |
| Quick Ratio | 3.61 | 5.59 | 6.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥819.33 Million | CN¥1.20 Billion | CN¥1.07 Billion |
Hangzhou Minsheng Healthcare Co Ltd - Advanced Valuation Insights
This section examines the relationship between Hangzhou Minsheng Healthcare Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.79 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | 15.6% |
| Total Assets | CN¥2.02 Billion |
| Market Capitalization | $622.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hangzhou Minsheng Healthcare Co Ltd's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Hangzhou Minsheng Healthcare Co Ltd's assets grew by 15.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Hangzhou Minsheng Healthcare Co Ltd (2021–2025)
The table below shows the annual total assets of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.02 Billion ≈ $295.16 Million |
+15.62% |
| 2024-12-31 | CN¥1.74 Billion ≈ $255.29 Million |
+5.87% |
| 2023-12-31 | CN¥1.65 Billion ≈ $241.13 Million |
+115.32% |
| 2022-12-31 | CN¥765.29 Million ≈ $111.99 Million |
+12.30% |
| 2021-12-31 | CN¥681.49 Million ≈ $99.72 Million |
-- |
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also p… Read more